MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/add.15030

Медицинская библиотека · Addiction (Abingdon, England) · 2020

Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.

Sufrin Carolyn, Sutherland Lauren, Beal Lauren, Terplan Mishka, Latkin Carl, Clarke Jennifer G

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND AIMS: The established standard care in pregnancy is medication for opioid use disorder (MOUD); however, many institutions of incarceration do not have MOUD available. We aimed to describe the number of incarcerated pregnant women with opioid use disorder (OUD) in the United States and jails' and prisons' MOUD in pregnancy policies.

DESIGN

Epidemiological surveillance study of 6 months of outcomes of pregnant, incarcerated women with OUD and cross-sectional survey of institutional policies.

SETTING

United States.

PARTICIPANTS

Twenty-two state prison systems and six county jails.

MEASUREMENTS: The number of pregnant women with OUD admitted and treated with methadone, buprenorphine or withdrawal; policies on provision of MOUD and withdrawal in pregnancy.

FINDINGS: Twenty-six per cent of pregnant women admitted to prisons and 14% to jails had OUD. One-third were managed through withdrawal. The majority who were prescribed MOUD were on methadone (78%, prisons; 81%, jails), not buprenorphine. While most sites (n = 18 prisons, n = four jails) continued pre-incarceration MOUD in pregnancy, very few initiated in custody (n = four prisons; n = two jails). Two-thirds of prisons and three-quarters of jails providing MOUD in pregnancy discontinued it postpartum.

CONCLUSIONS

In this sample of US prisons and jails, one-third required pregnant women with opioid use disorder to go through withdrawal, contrary to medical guidelines. More women were prescribed methadone than buprenorphine, despite the fewer regulatory barriers on prescribing buprenorphine. Most sites stopped medication for opioid use disorder postpartum, signaling prioritization of the fetus, not the mother. Pregnant incarcerated women with opioid use disorder in the United States frequently appear to be denied essential medications and receive substandard medical care.

Для цитирования: Sufrin Carolyn, Sutherland Lauren, Beal Lauren, Terplan Mishka, Latkin Carl, Clarke Jennifer G. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.. Addiction (Abingdon, England). 2020. DOI: 10.1111/add.15030.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.